Boehringer Ingelheim International GmbH

Allemagne


 
Quantité totale PI 4 723
Quantité totale incluant filiales 4 725 (+ 8 pour les filiales)
Rang # Quantité totale PI 228
Note d'activité PI 4/5.0    2 176
Rang # Activité PI 310
Parent C.H. Boehringer Sohn AG & Co. KG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 343 432
321 317
1 586 656
68
 
Dernier brevet 2025 - Tetrazole derivatives as trpa1 i...
Premier brevet 1980 - Method of eliminating opiate wit...
Dernière marque 2025 - EASi
Première marque 1965 - PERSANTINE

Filiales

4 subsidiaries with IP (8 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Scientific research in the field of prevention and treatment of metabolic and cardiovascular dise...
P/S Scientific research in the field of prevention and treatment of cardiovascular diseases; providin...
P/S Scientific research in the field of prevention and treatment of cardiovascular diseases; providi...
P/S Provision of medical research information and scientific information in the field of oncology
P/S Downloadable computer software and downloadable mobile applications for assisting patients with ...
2024 P/S Provision of medical research information and scientific information in the field of oncology.
P/S Provision of medical research information and scientific information in the field of oncology.
Invention Treatment for diabetes in patients with insufficient glycemic control despite therapy with an ora...
Invention Pharmaceutical composition, methods for treating and uses thereof. The present invention relates...
Invention Uses of dpp iv inhibitors. The specification describes the use of selected DPP IV inhibitors for...
P/S Scientific research in the field of prevention and treatment of metabolic disease; providing medi...
Invention Dpp iv inhibitor formulations. The present invention relates to pharmaceutical compositions of D...
P/S Medical and scientific research in the fields of metabolic diseases, providing medical and scient...
P/S Medical and scientific research in the fields of metabolic diseases; providing medical and scient...
Invention Cell-controlled perfusion in continuous culture. Methods of protein production in continuous per...
P/S Pharmaceutical preparations.
Invention Recombinant rhabdovirus encoding for a cd80 extracellular domain fc-fusion protein. The present ...
Invention Aldosterone synthase inhibitors for treating chronic kidney disease. The present invention relat...
Invention Cell retention device and method. The subject technology relates to a cell retention device and ...
Invention Nebulizer and cartridge. A cartridge and a nebulizer for nebulizing a fluid as well as a method ...
Invention Cardio- and renoprotective antidiabetic therapy. The present invention relates to a certain DPP-...
Invention Heteroaryl carboxamide compounds as inhibitors of ripk2. The present invention relates to compou...
Invention Cancer treatment with a her2 inhibitor and a cyp3a and/or p-gp modulator. The present invention r...
Invention Myeloid-derived growth factor for use in treating or preventing a liver disorder. The present inv...
P/S Scientific research in the field of prevention and treatment of metabolic diseases; providing med...
P/S Scientific research in the field of prevention and treatment of metabolic diseases; providing me...
P/S Medical and scientific research in the fields of metabolic diseases, providing medical and scien...
P/S Medical and scientific research in the field of mental health; providing medical and scientific r...
P/S Medical and scientific research in the field of mental health; providing medical and scientific ...
P/S Medical and scientific research in the field of inflammatory diseases; providing medical and scie...
P/S Medical and scientific research in the field of inflammatory diseases; providing medical and sci...
Invention Anti il-36r antibodies. The present invention relates to anti-IL-36R binding compounds, in parti...
P/S Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali...
P/S Medical and scientific research in the fields of metabolic diseases; providing medical and scien...
Invention Bispecific anti-vegf and anti-trkb binding molecules for the treatment of eye diseases. This inv...
Invention Inhibitors of trpc6 for treating focal segmental glomerulosclerosis. Disclosed are methods for tr...
Invention Inhibitors of trpc6 for treating focal segmental glomerulosclerosis. Disclosed are methods for t...
Invention Novel substituted pyrazine-carboxamide derivatives. The present invention relates to compounds o...
Invention Cardiosafe antidiabetic therapy. The present invention relates to cardio-safe antidiabetic therapy
Invention Cardio- and renosafe antidiabetic therapy. The present invention relates to cardio- and renosafe...
Invention Soluble guanylate cyclase activators for treating clinically significant portal hypertension and ...
Invention Anti-il-36r antibodies for the treatment of neutrophilic dermatoses. The present invention provi...
Invention Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase...
Invention R)-5-(hydroxymethyl)morpholine-2-carboxamides as agonists of sstr4. ciscis-5-(hydroxymethyl)morph...
Invention Process for the manufacture of a her2 inhibitor. The present invention relates to a process for t...
Invention Holding device for dispensing devices for substance dispensing of at least one therapeutically an...
Invention Methods for the treatment and prevention of gpp. The present invention relates to the treatment ...
Invention Methods for the treatment and prevention of gpp. The present invention relates to the treatment o...
Invention Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer. Th...
Invention Survivin as a biomarker for predicting the responsiveness of cancer treatment. The present invent...
Invention Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer. The...
Invention Uses of t cell engaging proteins in the treatment of cancer. The invention generally relates to t...
Invention Formulations to stabilize virus-based therapeutics. The present invention relates to viral formu...
Invention New therapeutic combinations for the treatment of progressive fibrosing interstitial lung disease...
Invention New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing int...
2023 Invention Tetrazole derivatives as trpa1 inhibitors. The present disclosure provides certain tetrazole der...
2022 Invention Methods and molecules for rna interference (rnai). The invention provides a method of suppressin...
Invention Trpc6 inhibitory compounds for treating sepsis. The present invention relates to compounds of fo...
Invention Adamts14 inhibition. Methods of treating and preventing fibrosis, and diseases/disorders charact...
Invention Novel tetrahydroquinolines and proteolysis targeting chimera (protacs) comprising them as degrade...
Invention Quantification method of polysorbate in aqueous formulations. The present disclosure is directed...
Invention Method of determining a future color value or corresponding property and arrangement therefor. T...
Invention Treatment and prevention of alcoholic liver disease. Methods of treating or preventing alcoholic...
Invention Process for purifying and enriching proteins, nucleic acids or viruses using an aqueous two-phase...